Location History:
- Jersualem, IL (2006)
- Jerusalem, IL (2007 - 2017)
- Mevasseret Zion, IL (2013 - 2022)
Company Filing History:
7 out of 894 
3 out of 3 Years Active: 2006-2022
Title: Gila Arad: Innovator in Peptide Research
Introduction
Gila Arad is a prominent inventor based in Mevasseret Zion, Israel. She has made significant contributions to the field of peptide research, particularly in the treatment of viral infections and inflammatory disorders. With a total of 8 patents to her name, her work has the potential to impact various therapeutic approaches.
Latest Patents
Among her latest patents, Gila Arad has developed peptides for use in the treatment of viral infections. These patents disclose peptides, compositions, combinations, kits, and methods aimed at treating viral pathogen infections. The combinations and kits include the disclosed peptides alongside additional antiviral therapeutic agents. Another notable patent focuses on the reduction of inflammatory disease symptoms through short peptides that inhibit signaling via CD28. This patent outlines a method for treating non-pathogen associated inflammatory disorders by administering an isolated peptide that specifically binds to an amino acid sequence within the dimer interface of a T cell costimulatory pathway member, particularly CD28 and CTLA4. The patent also covers pharmaceutical compositions that include the isolated peptide and its use in treating such disorders.
Career Highlights
Gila Arad has worked with esteemed organizations, including Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. and Atox Bio Ltd. Her innovative research has positioned her as a key figure in the scientific community, particularly in the realm of peptide therapeutics.
Collaborations
Throughout her career, Gila has collaborated with notable individuals such as Raymond Kaempfer and Anat Shirvan. These collaborations have further enriched her research and contributed to her success in the field.
Conclusion
Gila Arad's contributions to peptide research and her innovative patents highlight her role as a leading inventor in the scientific community. Her work continues to pave the way for advancements in the treatment of viral infections and inflammatory disorders.